Fei Tong

机构：Hebei Medical University, Nanchang University, Nanjing General Hospital of Nanjing Military Command, Second Hospital of Hebei Medical University · ORCID：0000-0002-9197-8260

发表论文 38 篇 · 总被引 589 次 · h-index 13

代表论文

• Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A (2022 · Theranostics · 被引 97)
• A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma (2022 · Neuro-Oncology · 被引 64)
• Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma (2023 · 癌症：英文版 · 被引 58)
• Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis (2022 · BMC Cancer · 被引 52)
• PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma (2022 · Theranostics · 被引 45)
• Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance (2023 · Cancer Biology and Medicine · 被引 22)